SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-097991
Filing Date
2019-04-04
Accepted
2019-04-04 17:03:33
Documents
4
Period of Report
2019-04-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d697564d8k.htm 8-K 19952
2 EX-1.1 d697564dex11.htm EX-1.1 185068
3 EX-5.1 d697564dex51.htm EX-5.1 7638
4 GRAPHIC g697564g46y34.jpg GRAPHIC 4476
  Complete submission text file 0001193125-19-097991.txt   220209
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 19732821
SIC: 2836 Biological Products, (No Diagnostic Substances)